P
Pandion Therapeutics
Pandion Therapeutics is Cambridge based healthcare Startup
About Pandion Therapeutics
Pandion Therapeutics is a biotechnology company focused on developing innovative treatments for autoimmune and inflammatory diseases. The company operates in the biopharmaceutical market, serving patients and healthcare providers. Pandion's business model revolves around its proprietary TALON (Therapeutic Autoimmune reguLatOry proteiN) drug design platform, which allows for the creation of modular precision medicine therapeutics. These therapeutics are engineered to achieve lasting therapeutic outcomes by selectively modulating the immune system. The company generates revenue through the development and potential commercialization of its drug candidates, as well as through partnerships and collaborations with other pharmaceutical companies.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Listing
- IPO 2020
News
Open roles
Pandion Therapeutics in the Cambridge ecosystem
The Pandion Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A8 investors entered at this stage
Polaris Partners
Roche Venture Fund
Versant VenturesSR One
- BIBioInnovation
Boxer Capital
Access Biotechnology
RA Capital Management
Series B and later3 investors entered at this stage
- BCBoxer Capital
- ABAccess Biotechnology
RA Capital Management
Source: Dealroom Talent Intelligence.
Global footprint
Patents
16 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
See Pandion Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

